A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
Antibodies that block the Wnt inhibitors sclerostin and DKK- 1 enhance bone formation and fracture repair. Here the authors show these monospecific antibodies induce compensatory mechanisms that limit efficacy, and have designed a sclerostin/DKK-1 bispecific antibody that promotes superior fracture...
Guardado en:
Autores principales: | Monica Florio, Kannan Gunasekaran, Marina Stolina, Xiaodong Li, Ling Liu, Barbara Tipton, Hossein Salimi-Moosavi, Franklin J. Asuncion, Chaoyang Li, Banghua Sun, Hong Lin Tan, Li Zhang, Chun-Ya Han, Ryan Case, Amy N. Duguay, Mario Grisanti, Jennitte Stevens, James K. Pretorius, Efrain Pacheco, Heidi Jones, Qing Chen, Brian D. Soriano, Jie Wen, Brenda Heron, Frederick W. Jacobsen, Emil Brisan, William G. Richards, Hua Zhu Ke, Michael S. Ominsky |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5b80b8c1d296447f878d119b9b8140cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.
por: Maarten van Dinther, et al.
Publicado: (2013) -
Sclerostin and Its Involvement in the Pathogenesis of Idiopathic Scoliosis
por: Elias S. Vasiliadis, et al.
Publicado: (2021) -
Ability of Accruals Prediction Models on the Basis of Jones Model in Prediction of Abnormal Accruals and
Publicado: (2013) -
Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease
por: Daniel Cejka
Publicado: (2021) -
Managerial Ability and Accruals Quality
por: Mousa Bozorgasl, et al.
Publicado: (2014)